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Objective: Selenium neutralizes interleukin-1b (IL-1b) induced inﬂammatory responses in chondrocytes.
We investigated potential mechanisms for this through in vitro knock down of three major selenopro-
teins, Iodothyronine Deiodinase-2 (DIO2), Glutathione Peroxidase-1 (GPX1), and Thioredoxin Reductase-
1 (TR1) in primary human chondrocytes.
Methods: Primary human chondrocytes were transfected with scrambled small interfering ribonucleic
acid (siRNA) or siRNA speciﬁc for DIO2, GPX1 and TR1. After 48 h, transfected cells were cultured in
serum free media for 48 h, with or without 10 pg/ml IL-1b for the ﬁnal 24 h. The efﬁciency of siRNAs was
conﬁrmed by quantitative Real Time-Polymerase Chain Reaction (qRT-PCR) and Western blot analysis.
The gene expression, by qRT-PCR, of cyclooxygenase-2 (COX2), IL-1b, and Liver X receptor (LXR) alpha
and beta was evaluated to determine the impact of selenoprotein knockdown on inﬂammatory responses
in chondrocytes.
Results: The messenger RNA (mRNA) expression of DIO2, GPX1, and TR1 was signiﬁcantly decreased by
the speciﬁc siRNAs (reduced 56%, P¼ 0.0004; 96%, P< 0.0001; and 66%, P< 0.0001, respectively).
Suppression of DIO2, but not GPX1 or TR1, signiﬁcantly increased (w2-fold) both basal (P¼ 0.0005) and
IL-1b induced (P< 0.0001) COX2 gene expression. Similarly, suppression of DIO2 signiﬁcantly increased
(w9-fold) IL-1b induced IL-1b gene expression (P¼ 0.0056) and resulted in a 32% (P¼ 0.0044) decrease
in LXRa gene expression but no effect on LXRb.
Conclusions: Suppression of the selenoprotein DIO2 resulted in strong pro-inﬂammatory effects with
increased expression of inﬂammatory mediators, IL-1b and COX2, and decreased expression of LXRa
suggesting that this may be the upstream target through which the anti-inﬂammatory effects of DIO2 are
mediated.
 2012 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.Introduction
Profound selenium deﬁciency is associated with the severe
osteoarthropathy known as Kashin-Beck Disease (KBD) that affects
around seven million individuals in China and neighboring
regions1. In the US, a low but non-deﬁciency level of selenium has
been shown to be associated with osteoarthritis (OA) presence and
severity in a large population study2,3. These observations suggest
a requirement for selenium for cartilage health and OA prevention.
Recently, selenium has been shown to be anti-inﬂammatory by
altering cytokine-inducible nitric oxide synthase (iNOS) and
cyclooxygenase-2 (COX2) gene expression in response toto: V.B. Kraus, Box 3416,
, USA. Tel: 1-919-681-6652;
s Research Society International. Plipopolysaccharide (LPS) stimulation in cultured macrophages4,5.
Our recent study demonstrated that pretreatment of chondrocytes
with selenomethionine (SeMet) attenuated production of inter-
leukin-1b (IL-1b) induced nitric oxide (NO) and prostaglandin E2
(PGE2), synthesized via the COX and PG synthase pathways6. Given
the fact that selenium is incorporated as selenocysteine at the
active site of a wide range of selenoproteins, we hypothesized that
one or more selenoproteins may be responsible for the anti-
inﬂammatory effects of selenium.
To date, 25 mammalian selenoproteins have been identiﬁed
including three large subfamilies: glutathione peroxidases (GPXs),
thioredoxin reductases (TRs), and iodothyronine deiodinases
(DIOs)7. GPXs and TRs function as antioxidative enzymes to catalyze
the reduction of intracellular peroxide and regulate the redox
balance in cells8. The DIOs regulate the bioactivity of thyroid
hormone by controlling levels of thyroxine (T4) and the active
hormone, 3,30,5-triiodo L-thyronine (T3)9. DIO2 is responsible forublished by Elsevier Ltd. All rights reserved.
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hormone, T3. Several studies now implicate speciﬁc selenoproteins
from all three of these subfamilies in OA. A genetic variant of GPX1
and reduced plasma GPX activity are associated with increased risk
of developing KBD, a severe form of OA endemic to China10. Gene
expression of GPX1 and thioredoxin-interacting protein (TXNIP) are
downregulated in cartilage lesions with moderate to severe late-
stage OA11. A variant of DIO2 is associated with risk for developing
OA12 and has been shown to increase the vulnerability of cartilage to
OA in associationwith non-optimal femoral head bone shapes rather
than directly inﬂuencing the formation of these shapes13. Taken
together, this evidence showsmodulation ofmajor selenoproteins in
OA and suggests that theymay be importantmodiﬁers of the joint to
inﬂammatory responses and thereby OA susceptibility. Our goal in
this study was to elucidate the biological effects of three speciﬁc
major selenoproteins through analysis of the consequences of DIO2,
GPX1 and TR1 knockdown with small interfering RNAs (siRNAs) on
inﬂammatory responses in primary human chondrocytes.
Materials and methods
Chondrocyte isolation and culture
Anonymous surgicalwaste articular cartilage samples, taken at the
time of joint replacement, were used for this project. Tissue was
collected under the approval of the Duke Institutional Review Board
(IRB)whodetermined that this protocolmet the deﬁnition of research
not involving human subjects as described in 45CFR46.102(f) and
satisﬁed the Privacy Rule as described in 45CFR164.514. Articular
cartilage samples were obtained from six patients undergoing total
knee replacement surgery [meanage, 60.310.3 years]. Cartilagewas
harvested from nonlesional areas, further minced, and subjected to
pronase and collagenase digestion to isolate primary human chon-
drocytes, similar to previously published methods14. Isolated chon-
drocytes within the ﬁrst two passages were used for all experiments.
RNA Interference of DIO2, GPX1 and TR1
siRNA transfectionwas performed using the program U20 of the
Amaxa Nucleofector (Gaithersburg, MD), with either the Amaxa
Primary Human Chondrocyte Nucleofector Kit or Mirus Ingenio
Electroporation Kit (Madison, MD) according to the manufacturers’
protocols. Chondrocytes were transfected with the following
siRNAs: 3 mg of Silencer Negative Control No.1 siRNA (Ambion,
Applied Biosystem) that served as a scrambled transfection control;
3 mg of human DIO2 speciﬁc siRNA (s4106); 1 mg of human GPX1
speciﬁc siRNA (s804); or 3 mg of human TR1 speciﬁc siRNA (s755).
After transfection, cells were cultured for 48 h in Dulbecco’s
Modiﬁed EagleMedium (DMEM)/F12media supplementedwith 10%
fetal bovine serum to allow gene suppression and turnover of the
preexisting targeted proteins. Transfected cells were subsequently
cultured in the absence of serum in DMEM media for 24 h, then
treated for another 24 h with or without 10 pg/ml IL-1b (R & D
systems, Minneapolis, MN) in serum free media. The IL-1b concen-
tration of 10 pg/ml was chosen based on evidence for physiological
relevance (equivalent to concentrations in human OA synovial ﬂuid)
andpreviouslyestablishedexperiments6,15,16. Thus, the total periodof
knockdownwas 96 h (72 h prior to the addition of IL-1b). Cells were
treatedwith RNeasy Lysis buffer (Qiagen Valencia, CA) to isolate RNA
for gene expression studies.
RNA isolation and Real Time-Polymerase Chain Reaction (RT-PCR)
Cell lysates, prepared by RNeasy Lysis buffer from each experi-
mental condition were homogenized by passage through aQIAshredder spin column (Qiagen, Valencia, CA). The total deoxy-
ribonucleic acid (DNA) and RNA fractions were further isolated
using the AllPrep DNA/RNA/Protein Mini Kit (Qiagen, Valencia, CA)
according to the manufacturer’s protocol. The isolated total RNA
was reverse transcribed into cDNA using the High Capacity cDNA
Reverse Transcription Kit (Applied Biosystems, Foster City, CA) for
RT-PCR analysis. The ABI Prism 7000 sequence detection system
and relative quantiﬁcation software (Applied Biosystems, Foster
City, CA) were used for real-time analyses. The ampliﬁcation for RT-
PCR used the following Applied Biosystems primer and probe sets:
18S rRNA endogenous control; Hs00255341_ml (DIO2);
Hs00829989_gH (GPX1); Hs00182418_ml (TR1); Hs01573474_g1
(COX2); Hs01555410_m1 (IL-1b); Hs00172855_ml Liver X receptor
(LXRa) and Hs00173195_ml (LXRb). The real-time reactions were
performed in triplicate in a ﬁnal volume of 25 ml.
mRNA quantiﬁcation and statistical analysis
Raw mRNA expression values were computed by 2ΔCt formula17
with values normalized to 18S rRNA, where ΔCt represents the
difference in Ct (threshold cycle) number of the 18S rRNA gene and
target genes. Results were derived from a total of four independent
experiments for COX2, IL-1b, LXRa and LXRb gene expression, per-
formed in triplicate, using a total of four separate primary chon-
drocyte cell lines. The relative fold changes inmRNAexpression levels
of target geneswere calculated by the 2ΔΔCt formula17, between cells
transfected with selenoprotein siRNA and the cells transfected with
scrambled siRNA in different treatments. For the purposes of graph-
ical presentation, the relative mRNA level in scrambled transfected
cells without treatment (control group) was set at 100%.
Raw mRNA expression data were evaluated by paired t-test of
the log transformed 2ΔCt values comparing subgroups (n¼ 4 in
each group from four separate cell lines): (1) the scrambled
transfected group without IL-1b treatment and individual seleno-
protein siRNA transfected groups without IL-1b treatment, and
(2) the scrambled transfected group with IL-1b treatment and
individual selenoprotein siRNA transfected groups with IL-1b
treatment. P values less than 0.05 were considered signiﬁcant after
correction for multiple comparisons (Bonferroni).
Western blot quantiﬁcation of protein knockdown
Whole cell lysateswere separated by SDS-PAGE and transferred to
nitrocellulose for immunoblotting.Membraneswereblockedwith5%
BSA in TBS/0.1% Tween 20 (TBS-T). Polyclonal primary antibodies
against DIO2, GPX1 and TR1were obtained from Abcam (Cambridge,
MA). A monoclonal antibody against a-tubulin (Sigma) was used as
a normalization control at 1:10,000 dilution. Anti-rabbit and anti-
mouse IgG-HRP (Jackson ImmunoResearch, West Grove, PA)
secondary antibodies were used at a 1:5,000 dilution. The resulting
ﬁlmswere scannedusingCanoScanLiDE70 (Canon, LakeSuccess, NY)
and the band intensities were quantiﬁed using Adobe Photoshop CS
and Image J (National Institutes of Health, Bethesda, MD).
Results
Suppression of selenoproteins by siRNA
To examine the effects of DIO2, GPX1 and TR1 on IL-1b
responses in primary human chondrocytes, we suppressed the
expression of DIO2, GPX1, and TR1 with sequence speciﬁc siRNAs
(Fig. 1). Compared with the scrambled siRNA control, the expres-
sion of the three selenoproteins was signiﬁcantly reduced by the
speciﬁc siRNAs: DIO2 siRNA reduced DIO2mRNA expression by 56%
(P¼ 0.0004) [Fig. 1(A)]; GPX1 siRNA reduced GPX1 mRNA
Fig. 1. Demonstration of siRNA suppression of DIO2, GPX1 and TR1 steady state mRNA gene and protein expression. Primary human chondrocytes were transfected with
a scrambled control siRNA or siRNA speciﬁc for DIO2, GPX1 or TR1. At 48 h post-transfection, siRNA transfected cells were cultured for 48 h in serum-free medium. (A) DIO2, GPX1
and TR1 steady-state mRNA levels were determined by RT-PCR normalized to 18S rRNA in siRNA-transfected cells (average of triplicates for four independent experiments). Values
are the mean and SEM levels of mRNA for DIO2, GPX1 or TR1 expressed as a percentage of the scrambled control. The mRNA level in cells transfected with the scrambled siRNA was
set at 100%. ***P< 0.001 vs scrambled control (scrambled). The mean fold change as % control and 95% CIs corresponding to each gene target are provided in the tables in each panel.
(B) DIO2, GPX1 and TR1 proteins were isolated. Equal amounts of total cell lysate were separated by SDS-PAGE and analyzed by Western blot; a-tubulin (bottom row) was used as
a control for normalization.
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expression by 66% (P< 0.0001). By Western blot, protein levels
were reduced 50% by the DIO2 siRNA, 80% by the GPX1 siRNA, and
80% by TR1 siRNA [Fig. 1(B)].
COX2 gene expression in the setting of suppressed selenoprotein
expression
The suppression of DIO2 had a pro-inﬂammatory effect; it
resulted in a 2-fold increase in COX2 basal (absence of IL-1b) mRNA
expression (P¼ 0.0005) [ Fig. 2(A)]]. The suppression of DIO2 also
resulted in a signiﬁcant 2-fold increase in IL-1b induced COX2steady state mRNA expression (P< 0.0001) compared to the IL-1b
induced COX2 level of gene expression in the presence of the
scrambled siRNA control. In contrast, the suppression of GPX1 and
TR1 had no signiﬁcant effect on basal level expression of COX2.
Depletion of GPX1 slightly but signiﬁcantly decreased IL-1b
induced COX2 gene expression (P¼ 0.007).
IL-1b gene expression in the setting of suppressed selenoprotein
expression
Based on a report of an inverse relationship of DIOs and IL-1b
gene expression in skeletal muscle18, we next evaluated the effects
Fig. 2. Effect of depleting selenoproteins on COX2 and IL-1b gene expression in primary
chondrocytes. Primary human chondrocytes were transfected with a scrambled control
siRNA or siRNA speciﬁc for DIO2, GPX1 and TR1. At 48 h post-transfection, siRNA
transfected cells were cultured for 24 h in serum free medium and followed by 24 h
treatment with or without 10 pg/ml IL-b. Gene expression for COX2 and IL-1b was
determined by RT-PCR normalized to 18S rRNA (average of triplicates for four inde-
pendent experiments). The effect of depleting individual selenoproteins on COX2 (A) and
IL-1b (B) gene expression is shown in the absence or presence of IL-1b (10 pg/ml)
treatment. Values shown are mean and SEM of COX2 or IL-1b gene expression as
a percentage of the scrambled control without IL-1b (set at 100%) from four independent
experiments. # P< 0.001 vs scrambled without IL-1b; ***P< 0.001 vs scrambled with
IL-1b stimulation; **P< 0.01 vs scrambled with IL-1b stimulation *P< 0.05 vs scrambled
with IL-1b stimulation. The mean fold change as % control and 95% CIs corresponding to
each experimental condition are provided in the tables in each panel.
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human chondrocytes. Similar to the effect on COX2 gene expres-
sion, the suppression of DIO2 had a pro-inﬂammatory effect; it
resulted in a 2-fold increase in IL-1b basal steady state mRNAFig. 3. Effect of depleting DIO2 on LXRa and LXRb gene expression in primary chondrocyt
siRNA speciﬁc for DIO2, GPX1 and TR1. At 48 h post-transfection, siRNA transfected cells w
without 10 pg/ml IL-b. Gene expression for LXRa and LXRb was determined by RT-PCR norm
of depleting DIO2 on LXRa (A) and LXRb (B) gene expression is shown in the absence or pres
gene expression as a percentage of the scrambled control without IL-1b (set at 100%) from
scrambled without IL-1b stimulation; *P< 0.05 vs scrambled without IL-1b stimulation. T
condition are provided in the tables in each panel.expression but the result did not meet statistical signiﬁcance
(P¼ 0.2837) [Fig. 2(B)]. However, the suppression of DIO2 resulted
in a 9-fold increase in IL-1b induced IL-1b steady state mRNA
expression (P¼ 0.0056) over that induced by IL-1b stimulation in
the presence of the siRNA scrambled control. The suppression of
GPX1 and TR1 had no signiﬁcant effect on basal level expression of
IL-1b. The suppression of TR1 had a slight but statistically signiﬁ-
cant pro-inﬂammatory effect with an increase in the IL-1b induced
IL-1b mRNA expression (P¼ 0.0140) beyond the level achieved by
IL-1b in the presence of the scrambled siRNA control.
LXR gene expression in the setting of suppressed DIO2 expression
Based on the known regulation of IL-1b and PGE2 production, and
regulation of LXRs by thyroid hormone in liver cells19,20, we next
tested the hypothesis that DIO2 modiﬁes inﬂammatory responses in
chondrocytes through regulation of LXR gene expression in chon-
drocytes. We therefore examined LXRa and LXRb gene expression
under DIO2 depleted conditions. With respect to LXRa, the suppres-
sion of DIO2 also resulted in a pro-inﬂammatory effect with a signif-
icant decrease (32%, P¼ 0.0044) in LXRa basal mRNA expression
compared to the scrambled control [Fig. 3(A]. IL-1b treatment
signiﬁcantly decreased the LXRamRNA expression (63%, P¼ 0.0004)
and the combination of IL-1b and suppression of DIO2 did not further
repress LXRa expression. In contrast to the effect on LXRa gene
expression, there were no changes in LXRb gene expression in
response to depletion of DIO2 or IL-1b treatment [Fig. 3(B)].
Discussion
Our study highlights a potential new role of DIO2 in modulating
the inﬂammatory response in chondrocytes. Suppression of DIO2
by siRNA knockdown resulted in consistent pro-inﬂammatory
effects in primary human chondrocytes, namely downregulation
of LXRa, and upregulation of both IL-1b and COX2 gene expression.
These results suggest that DIO2 plays an important anti-
inﬂammatory role in cartilage through local chondrocyte produc-
tion of thyroid hormone T3 that maintains or activates LXRa, which
in turn suppresses IL-1b and COX2 gene expression. In this manner,
DIO2 would function as an important countermeasure to inﬂam-
matory responses in chondrocytes.
This interpretation is consistent with a variety of evidence from
several past studies. For one, this is consistent with a previous studyes. Primary human chondrocytes were transfected with a scrambled control siRNA or
ere cultured for 24 h in serum free medium and followed by 24 h treatment with or
alized to 18S rRNA (average of triplicates for four independent experiments). The effect
ence of IL-1b (10 pg/ml) treatment. Values shown are mean and SEM of LXRa and LXRb
four independent experiments. ***P< 0.001 vs scrambled without IL-1b; **P< 0.01 vs
he mean fold change as % control and 95% CIs corresponding to each experimental
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with IL-1b mRNA in skeletal muscle18. Our ﬁndings are also
consistent with data showing that thyroid hormone (T3) upregu-
lates LXRa but not LXRb gene expression in mouse liver cells20.
Activation of LXR decreases basal and IL-1b induced PGE2
production in human cartilage explants19. This supports our
conclusion that DIO2 regulation of LXRa in this study likely medi-
ated the alteration of COX2 gene expression. IL-1b also greatly
downregulates LXRa, but not LXRb gene expression in human OA
cartilage21. Given that stimulation of LXR transcriptional activity
can counteract the catabolic effects of IL-121, the activation or
maintenance of LXRa activity by thyroid hormone (produced by
DIO2), appears to be one of the mechanisms by which DIO2 exerts
a protective anti-inﬂammatory effect in chondrocytes. This is
therefore one pathway and selenoprotein through which selenium
may exert an anti-inﬂammatory effect. The general lack of major
modulation of the inﬂammatory responses due to GPX1 and TR1
knockdown underscores the speciﬁcity of these observations of
pro-inﬂammatory effects due to lack of DIO2 and the corollary, that
speciﬁc anti-inﬂammatory effects are attributable to DIO2.
Although we only achieved modest knockdown of DIO2, we
observed strong effects. Like the GPXs and TRs, there is some
redundancy of functionwithin the DIO family of genes consisting of
DIO1, DIO2 and DIO3. DIO1 and DIO2 are responsible for conversion
of the prohormone T4, to its active form, T3 through deiodination.
DIO3 inactivates T4 and T3 through deiodination, while DIO1 also
catalyzes deiodination of T3 to inactive 3,30-diiodothyronine (T2).
Only DIO2 and DIO3 are known to be expressed in chondrocytes22.
To date, genetic polymorphisms in both DIO2 and DIO3 have been
implicated in OA susceptibility12,23 although the mechanisms are
not known. DIO2 expression is highly upregulated in cartilage of
late stage OA24. It has been demonstrated previously that DIO2
gene expression was potently activated in response to LPS stimu-
lation via the nuclear factor kB (NFkb) pathway in a human
mesothelioma cell line25. Therefore, the elevated DIO2 expression
in OA cartilage could be a consequence of an activated NFkb
pathway activity among other pro-inﬂammatory pathways during
OA disease progression26. The ﬁndings in this study support the
supposition that the local availability of thyroid hormone plays
a protective role and that optimal DIO2 activity is essential for
maintenance of normal chondrocyte health through production of
adequate local T3 concentrations. It is possible however that both
depletion (in our study) or overproduction of DIO2 (in another
study24) may lead to aberrant local levels of T3 and contribute to
joint pathology. Further elucidation of the mechanism by which
DIO2 or T3 modulate the inﬂammatory response would be bene-
ﬁcial in determining the optimal DIO2 activity and T3 concentra-
tions for joint health.
There are several limitations of this research. It was interesting
that profound depletion of GPX1 (both mRNA and protein) did not
have a signiﬁcant impact on COX2 or IL-1b gene expression. Thismay
however be due to redundancy of this important family of antioxi-
dants. At least three other GPX enzymes (GPX2, GPX3 and GPX4) are
known to be expressed in cartilage and chondrocytes11 (and
unpublished observation). Similarly, the failure to observe major
effects from the TR1 knockdown may be due to redundancy of this
family with TRs like TR2 known to be expressed in chondrocytes27.
Thus, it may be necessary to simultaneously knockdown several
GPXs or TRs or requiremultiple siRNAs for a particular target tomore
fully suppress the expression and activity of these selenoproteins. It
may also require a longer period of knockdown than 72 h prior to
cytokine addition to more fully evaluate the role of these seleno-
proteins in joint tissue inﬂammation and joint degradation;
although, several recent siRNA knockdown studies in other cell
systems demonstrated appreciable reductions of enzymatic activityafter 48 h transient transfectionwith siRNA (GPX1 or TR1) as well as
reduced expression of a T3-driven promoter after 48 h transfection
into a cell line stably transfected with shRNA (DIO2)28e30.
Although we observed both mRNA and protein levels of sele-
noproteins were decreased in siRNA transfected cells, we did not
measure their corresponding enzymatic activities. However, prior
siRNA studies of these selenoproteins demonstrated a strong
concordance of reductions in mRNA steady state and protein levels
with reductions in enzymatic activity levels28e30. Furthermore, we
previously demonstrated that decreases in COX2 steady state
transcript levels corresponded to decreases in PGE2, its enzymatic
product6.
Finally, although we focused on the effects of depleting DIO2,
GPX1 and TR1, we cannot exclude the possibility that depletion of
these selenoproteins may impact the expression of other seleno-
proteins. For instance, profound depletion of GPX1 may trigger
compensatory gene expression of other antioxidative enzymes.
In conclusion, we have demonstrated that depletion of DIO2
increased IL-1b induced COX2 gene expression in chondrocytes.We
also showed that depleting DIO2 increased IL-1b induced IL-1b
gene expression, which suggests that DIO2 may negatively modu-
late the IL-1b response through regulation of IL-1b gene expression
itself. Finally, we demonstrated that depleting DIO2 decreased the
anti-inﬂammatory LXRa gene expression and this may contribute
to the increased IL-1b and COX2 gene expression under DIO2
depleted conditions. These data are consistent with a view that
DIO2 in chondrocytes may constitutively maintain or activate LXRa
gene expression with downstream effects of decreased IL-1b and
COX2 expression and PGE2 production.
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